Key result
NSTEMI presentation at urban noncardiac hospitals links to ~15% higher long-term CV mortality versus specialized centres.
Why the study?
While treatment delays worsen STEMI outcomes, their effect in NSTEMI is less clear across different presentation sites.
Does initial presentation to nonspecialized hospitals worsen cardiovascular mortality and MACE in adult NSTEMI patients compared to specialized cardiac centres?
Cohort (n=30,817)
Yes
Does initial presentation to nonspecialized hospitals worsen cardiovascular mortality and MACE in adult NSTEMI patients compared to specialized cardiac centres?
NSTEMI patients presenting to nonspecialized hospitals experience delayed catheterization and worse short- and long-term cardiovascular outcomes compared to those presenting directly to specialized cardiac centers.
Answers are grounded in this paper and cite their sources.
Supports triage of NSTEMI to cardiac centers when feasible; leaves open whether presentation site causally affects mortality.
Abstract Background Although delays in treatment are known to worsen outcomes in ST-elevation myocardial infarction, their effect in non-ST-elevation myocardial infarction (NSTEMI) is less clear. Care quality and timely revascularization should be comparable across presentation sites to optimize patient outcomes. Methods Using the Manitoba Centre for Health Policy data, we retrospectively analyzed adult NSTEMI patients who underwent cardiac catheterization and revascularization from January 2001 to March 2021. Patients were grouped by initial presentation site—rural hospital, urban noncardiac hospital, or specialized cardiac centre. We assessed in-hospital, 1-year, and long-term outcomes. Results Of 30,817 NSTEMI patients, 19,482 underwent catheterization, and 12,567 received revascularization. Distribution by site was as follows: 44% at cardiac centres, 28.5% at urban noncardiac hospitals, and 27.5% at rural hospitals. Urban noncardiac hospital patients experienced significantly higher cardiovascular mortality in-hospital (hazard ratio [HR] 1.64; 95% confidence interval [CI] 1.09-2.47), at 1 year (HR 1.30; 95% CI 1.11-1.53), and over an average 6.65-year follow-up period (HR 1.15; 95% CI 1.07-1.24). Rural hospital patients showed a lower mortality incidence, potentially due to selection bias if critically ill patients did not survive the transfer. Both rural and urban noncardiac cohorts had elevated rates of major adverse cardiovascular events at all follow-up intervals. Time to catheterization was notably delayed for nonspecialized sites (cardiac centre, 0.83 ± 1.90 vs urban noncardiac 3.20 ± 3.05 vs rural, 3.09 ± 2.56 days; P < 0.001). Conclusions NSTEMI patients presenting to rural and urban nonspecialized hospitals experience worse short- and long-term outcomes, including increased incidence of major adverse cardiovascular events and mortality. These findings highlight the need for strategies to reduce disparities in access to specialized cardiac care.
No takes yet. Share an insight, caveat, or question.
Wiens et al. (2025) conducted a cohort in Non-ST-elevation myocardial infarction (NSTEMI) (n=30,817). Initial presentation to urban noncardiac or rural hospital vs. Specialized cardiac centre was evaluated on Long-term cardiovascular mortality (urban noncardiac vs specialized cardiac centre) (HR 1.15, 95% CI 1.07-1.24). Presentation of NSTEMI patients to urban noncardiac hospitals was associated with higher long-term cardiovascular mortality compared to specialized cardiac centres.
Synapse has enriched 10 related papers. Consider them for comparative context: